Bufei Huoxue capsule attenuates COPD-related inflammation and regulates intestinal microflora, metabolites

• Главные авторы: Yuanyuan Li (Автор), Jiali Chen (Автор), Yue Xing (Автор), Jian Wang (Автор), Qiuling Liang (Автор), Jiamin Zeng (Автор), Siyi Wang (Автор), Qiong Yang (Автор), Jianing Lu (Автор), Jieying Hu (Автор), Wenju Lu (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2024-04-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: Bufei Huoxue capsule (BFHX) is widely used for the clinical treatment of chronic obstructive pulmonary disease (COPD) in China.Objectives: The aim of this study is to explore the effects on COPD and the underlying mechanism of BFHX.The process and methods: In this study, we established a...